Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

MediStem Laboratories

Medistem Laboratories is an innovative biotechnology company committed to the creation and commercialization of advanced medical therapies based on non-controversial adult stem cells. Medistem's corporate mission is to transform these stem cells into valuable medical treatments. The Company's business strategy calls for the establishment of a series of clinics and laboratories around the world to deliver unprecedented, next-generation cell therapies to help millions of patients while seeking to commercialize products in the U.S. market. Clinic treatments use proprietary technology and cells sourced from umbilical cords, fat, bone marrow, and muscle for the treatment of cerebral palsy, stroke, cardiovascular disease and orthopedic diseases. Medistem believes it may hold a substantial competitive edge in the worldwide emerging market for stem cell-sourced medical solutions, positioning it to become a leading global provider of stem cell treatments on a fee-for-service basis, while accumulating intellectual property based on clinical and laboratory findings.


Contact Details:
2027 E. Cedar Street Suite 102
Tempe
AZ
85281
United States of America
Tel:(954) 727-3662
Fax:(954) 206-0637
Email:
WWW:

www.medisteminc.com/




Loading...

Recent Publications by MediStem Laboratories:

Exosomes as a tumor immune escape mechanism: possible therapeutic implications.
Advances in cancer therapy have been substantial in terms of molecular...
27th September, 2008
Medistem Laboratories J Transl Med. 2008 Jul 22;6:37.
DOI Direct Link
Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy.
Regenerative treatment of dilated, non-ischaemic cardiomyopathy represents...
22nd August, 2008
Medistem Laboratories Inc., 2027 E Cedar Street Suite 102 Tempe, AZ 85281, Reprod Biomed Online. 2008 Jun;16(6):898-905.

BioNews Results for MediStem Laboratories:

Abbott's Niaspan Reverses Artery Narrowing Versus Zetia
Lloyd's:  Nov 16 2009 12:22AM Matching: laboratories
Abbott's Niaspan Reverses Artery Narrowing Versus Zetia
CNN Money:  Nov 15 2009 11:30PM Matching: laboratories
Abbott's Niaspan Reverses Artery Narrowing Versus Zetia
Nasdaq:  Nov 15 2009 11:28PM Matching: laboratories
Nycomed reports continued satisfactory performance in the third quarter 2009
World Pharma News:  Nov 15 2009 12:42AM Matching: laboratories
PanGenetics signs agreement with Abbott Laboratories for PG110
TradingMarkets:  Nov 13 2009 7:14PM Matching: laboratories
Promote your company here: BioNewsCast - Press Release Distribution

View more MediStem Laboratories news.

MediStem Laboratories (MDSM.OB) Financial information Links from Barchart

MDSM.OB Quote from from Barchart.com
MDSM.OB Chart from from Barchart.com
MDSM.OB Profile from from Barchart.com
MDSM.OB Opinion from from Barchart.com

View more MediStem Laboratories finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 402 times since April 2007, the link to the organisation's website has been followed 74 times

Recent Search Terms used to find this page: medistem | medistem tempe az | .

Search for more companies in Tempe

Search for more companies in AZ



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for MediStem Laboratories

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.